Danish Agency To Buy New Pharmacovigilance System
DMA Under Pressure To Comply With Deadline For Mandatory E2B(R3) Format
Executive Summary
Rather than develop a new drug safety monitoring system from scratch, the Danish Medicines Agency is looking for a readymade solution.
You may also be interested in...
EU Makes ISO Format Mandatory For Side-Effect Reporting From June 2022
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.